Albert Ribera
Impact in
- Physiology top 5%
- Lysosomal Storage Disorders Research
- Adipose Tissue and Metabolism
- Ophthalmology top 5%
- Retinal Diseases and Treatments
Papers in
-
- Lysosomal Storage Disorders Research 7
-
- Retinal Diseases and Treatments 2
- Co-authors
- Fátima Bosch (15 shared papers)Virginia Haurigot (10 shared papers)Jesús Ruberte (9 shared papers)Pilar Villacampa (8 shared papers)Sara Marcó (8 shared papers)Sandra Motas (6 shared papers)SERGIO A. MUÑOZ (5 shared papers)Carles Roca (8 shared papers)
- Journals
- Diabetes (3 papers)Molecular Therapy (2 papers)Molecular Therapy — Methods & Clinical Development (2 papers)Journal of Biological Chemistry (2 papers)Human Molecular Genetics (2 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Albert Ribera
17 papers receiving 977 citations
Peers
Comparison fields: 5 of 50
- Physiology 351
- Ophthalmology 67
- Genetics 157
- Aging 3
- Molecular Biology 119
Countries citing papers authored by Albert Ribera
This map shows the geographic impact of Albert Ribera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Ribera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Ribera more than expected).
Fields of papers citing papers by Albert Ribera
This network shows the impact of papers produced by Albert Ribera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Ribera. The network helps show where Albert Ribera may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert Ribera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 255 | |
| 2 | 2013 | 187 | |
| 3 | 2013 | 72 | |
| 4 | 2012 | 62 | |
| 5 | 2009 | 59 | |
| 6 | 2016 | 57 | |
| 7 | 2014 | 49 | |
| 8 | 2011 | 47 | |
| 9 | 2017 | 46 | |
| 10 | 2014 | 31 | |
| 11 | 2021 | 30 | |
| 12 | 2021 | 30 | |
| 13 | 2012 | 25 | |
| 14 | 2013 | 21 | |
| 15 | 2016 | 19 | |
| 16 | 2024 | 11 | |
| 17 | 2024 | 1 |
About Albert Ribera
Albert Ribera is a scholar working on Physiology, Ophthalmology, Genetics, Molecular Biology and Nuclear Energy and Engineering, having authored 17 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (7 papers), Fibroblast Growth Factor Research (3 papers), Retinal Diseases and Treatments (2 papers), Virus-based gene therapy research (2 papers), Diabetes and associated disorders (1 paper) and Retinal Development and Disorders (1 paper). The work is most often cited by research in Physiology (351 citations), Ophthalmology (67 citations), Genetics (157 citations), Aging (3 citations) and Molecular Biology (119 citations). Albert Ribera has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Fátima Bosch, Virginia Haurigot, Jesús Ruberte, Pilar Villacampa, Sara Marcó, Sandra Motas, SERGIO A. MUÑOZ, Carles Roca, Maria Molas and Eduard Ayuso. Their work appears in journals such as Diabetes, Molecular Therapy, Molecular Therapy — Methods & Clinical Development, Journal of Biological Chemistry and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.